Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02191358 · ClinicalTrials.gov registry record
YouScript IMPACT Registry
A clinical trial, sponsored by Genelex Corporation.
- Completed
- Registry status
- 800
- Enrollment target
NCT02191358: Completed study, sponsored by Genelex Corporation.
NCT02191358 is a clinical trial that has completed, run by Genelex Corporation. The registered enrollment target is 800 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02191358 has completed, sponsored by Genelex Corporation.
- COMPLETED
- Registry status
- 800 participants
- Enrollment target
Study Summary
This multicenter observational study aims to investigate the benefits of providing pharmacogenetic testing with the YouScript Personalized Prescribing System which includes a clinical decision support tool and individualized pharmacist recommendations to elderly polypharmacy patients who are most at risk of adverse drug events. The YouScript system is unique in identifying drug-gene, and drug-drug-gene interactions that are missed by existing systems, and represent over 35% of significant interaction warnings. Data analysis will assess the impact of recommendations for medication changes on clinical decision making, patient outcomes, and healthcare resource utilization to determine which medications, specialties, or patient segments derive the greatest benefit from this intervention. Data gathered from patients enrolled in this study will be compared to patients matched on key characteristics from Inovalon's MORE2 healthcare database.
Primary Outcome
The primary objective is to determine the impact of the YouScript Personalized Prescribing System on healthcare resource utilization. This will involve comparing the number of hospitalizations, number of ER visits, number of provider office visits, number of radiographic procedures, and number of surgeries for the tested group versus the untested group.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2014-10 |
| Est. Completion | 2015-08 |
What the finished NCT02191358 record still lists
NCT02191358 is an observational study that tracks outcomes without assigning an intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02191358 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02191358 about?
NCT02191358 is a clinical study titled "YouScript IMPACT Registry". This multicenter observational study aims to investigate the benefits of providing pharmacogenetic testing with the YouScript Personalized Prescribing System which includes a clinical decision support tool and individualized pharmacist recommendations to elderly polypharmacy patients who are most at...
What is the current status of trial NCT02191358?
This trial is currently completed. The enrollment target is 800 participants. The study started on 2014-10. Estimated completion is 2015-08.
Who is sponsoring clinical trial NCT02191358?
This trial is sponsored by Genelex Corporation, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia